Lv1
88 积分 2024-04-20 加入
Optimizing In Vivo CAR-T Cell Engineering for Cancer Immunotherapy
1个月前
已完结
Endogenous CD28 drives the persistent activity of CAR T cells in myeloma and lymphoma models
1个月前
已完结
pTɑ Enhances CAR T-cell Function to Eradicate Liquid and Solid Tumors
1个月前
已完结
Base Editing Might Be Key to CAR T-cell Therapy
1个月前
已关闭
Chimeric antigen receptor T-cell therapy and bispecific antibody sequence for large B-cell lymphoma: a systematic review and meta-analysis
2个月前
已完结
Bone Metastatic Progression of Prostate Cancer Is Regulated by TRIM28–LDHA-Mediated Metabolism
3个月前
已关闭
Cost Effectiveness of Tremelimumab Plus Durvalumab for Unresectable Hepatocellular Carcinoma in the USA
3个月前
已完结
Cost–effectiveness of BTK inhibitors vs bendamustine and rituximab in chronic lymphocytic leukemia patients
3个月前
已完结
HSR25-203: Cost-Effectiveness Evaluation of Bruton Tyrosine Kinase Inhibitor (BTKi) Treatments Among Medicare Patients With Chronic Lymphocytic Leukemia (CLL) in First-Line (1L) and Relapsed/Refractory (R/R) Settings
3个月前
已关闭
Ibrutinib and PD-1 blockade potentiate mesothelin-targeting CAR-T cell therapy in preclinical models of pancreatic cancer
3个月前
已完结
皖公网安备34019202002308
